Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$24,410,801
+$7,602,925 QoQ
Shares Held
20,352
+11.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#210
of 2,003 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $69,954,680 across 17 Drug Manufacturers - General names. LLY ranks #1 (34.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
20,352 | $24,410,801 | |
| 2 | ABBV |
AbbVie Inc.
|
52,930 | $13,319,305 | |
| 3 | JNJ |
Johnson & Johnson
|
38,760 | $9,843,877 | |
| 4 | PFE |
Pfizer Inc
|
228,411 | $5,500,136 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,895 | $3,970,007 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
57,120 | $3,291,254 | |
| 7 | AMGN |
Amgen Inc
|
8,216 | $2,975,177 | |
| 8 | NVO |
Novo Nordisk A S
|
30,253 | $1,450,328 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,410,801 | 20,352 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $16,807,876 | 18,274 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $19,607,538 | 18,245 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $13,425,748 | 17,596 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $12,127,927 | 15,558 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $13,052,681 | 15,804 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $10,801,052 | 13,991 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $9,382,990 | 10,591 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $10,251,617 | 11,323 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $8,337,397 | 10,717 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $6,705,911 | 11,504 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $5,958,383 | 11,093 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $3,321,785 | 7,083 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,419,393 | 7,045 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $5,377,482 | 14,699 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $4,723,496 | 14,608 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $4,310,637 | 13,295 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $3,807,289 | 13,295 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $752,699 | 2,725 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $763,389 | 3,304 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $804,926 | 3,507 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $719,630 | 3,852 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $684,983 | 4,057 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $656,468 | 4,435 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $712,541 | 4,340 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $594,970 | 4,289 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||